Currently she is involved in translational research in lung cancer, with special interest in neuroendocrine lung tumors, driver mutations and oligometastatic disease.
Since January 2021 she is chair of the EORTC lung cancer group. She was involved in the EORTC initiatives to develop a consensus definition on synchronous oligometastatic NSCLC and a consensus definition of resectability of stage III NSCLC. She is the lead-author of the revised ESMO guideline on SCLC. She is member of IASLC, AACR, ASCO, ERS, ESMO and ETOP. She is associate editor of the Journal of Thoracic Oncology and editorial board member of the International IASLC Lung Cancer News. She has (co)-authored more than 300 publications and book chapters.